DUOS Snags $130M to Advance AI, Grow Payer Partnerships
DUOS' $130 million raise was led by FTV Capital and included participation from Forerunner Ventures.
DUOS' $130 million raise was led by FTV Capital and included participation from Forerunner Ventures.
Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits.
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
Venteur's $20 million funding round was led by Informed Ventures and American Family Ventures. In total, the company has raised $30 million.
Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment.
Millie’s Series A round was co-led by TMV and Foreground Capital. The financing will help the company expand its offerings and footprint.
HiLabs' Series B funding round was led by Denali Growth Partners and Eight Roads Ventures and included participation from F-Prime Capital. In total, HiLabs has raised about $41 million.
The Dublin-based pathology software and services provider will use the funds to support global growth and launch an on-demand, online pathology service in the U.S.
Mahmee raised $9.2 million in Series A funding led by Goldman Sachs Asset Management. The startup's CEO, Melissa Hanna, saw the raise as clear recognition of the progress Mahmee has made in tackling disparities in maternal care.
The San Francisco startup, which helps families find caregivers for their aging loved ones, will use the money from the round led by Javelin Venture Partners to expand and onboard additional caregivers.
Baltimore, Maryland-based startup Protenus has raised $11 million in a Series B round led by Kaiser Permanente Ventures and F-Prime Capital Partners. Arthur Ventures, LionBird Venture Capital and Cognosante Ventures also participated.
New York City-based Quartet has raised $40 million in a Series C round led by Polaris Partners and F-Prime Capital Partners. It also announced that it's teaming up with a payer: Horizon Blue Cross Blue Shield of New Jersey.
The fundraise will help the company expand its workforce, especially in sales, marketing and account management.
Vertical Venture Partners, which put an undisclosed amount of seed funding into Zipari in September 2014, led the round.
Most of the startups we’ve backed at Homebrew don’t rush to announce their funding. Not because they’re all operating in stealth or pre-product – in fact some already are earning $1M+ in revenue per annum. They just don’t feel the need to draw attention to themselves or alert possible competitors. And my sense is the trend carries […]
Daily, at-home blood glucose testing gives diabetics a way to monitor their glycemic control over the short term, and HbA1c testing gives a better picture long-term. Epinex Diagnostics Inc., a company developing a device to give doctors and patients an indication of their glycemic control over an intermediate term, revealed in a regulatory filing last […]